Bloodstream Infections in Kids Significantly Reduced With Quality Improvement Initiatives
Bloodstream infections associated with catheters can be significantly reduced through quality improvement efforts, possibly leading to better health outcomes and lives saved, decreased stays at the hospital and related costs, according to a new study.
The Cincinnati Childrens
"We were able to reduce the incidence of bloodstream infections after implementing a central line insertion and maintenance bundle, said Derek S. Wheeler, MD, a critical care physician at Cincinnati Childrens and the studys lead author. "This bundle emphasizes full sterile barrier precautions and chlorhexidine skin preparation during insertion, as well as daily discussion of catheter necessity and meticulous site and tubing care. Wheeler is also an assistant professor of clinical pediatrics at the University of Cincinnati College of Medicine.
The study will be presented at 7 p.m. ET Monday, May 3 at the annual Pediatric Academic Societies (PAS) meeting in
The study is one of two presented by Wheeler and colleagues this year at PAS that deal with catheter-associated bloodstream infections. The second study shows that a hospital-wide quality improvement collaborative resulted in a significant reduction in the incidence rate, from a baseline of 3.0 per 1,000 line days to less than 1.0 per 1,000 line days.
The collaborative approach included hospital-wide implementation of the same central line insertion and maintenance bundle on three critical care units, one oncology unit, one bone marrow transplant unit, and general medical/surgical units.
Catheter-associated bloodstream infections (CA-BSI) comprise the vast majority of hospital-acquired BSI in pediatric patients and are associated with increased length of stay (LOS), hospital costs and mortality.
Wheeler conducted the study in collaboration with researchers from Nationwide Childrens Hospital in
Related Stories
UC expert weighs in on current MASH treatment approaches
June 5, 2026
As MedCentral recently reported, pending broader pharmacologic approvals for metabolic dysfunction-associated steatohepatitis (MASH), lifestyle modifications remain the go-to intervention.
At least two weather patterns increase headaches, UC study suggests
June 4, 2026
University of Cincinnati physicians and collaborators identified two specific weather patterns that increase headache and migraine risk and found the preventive medication fremanezumab (Ajovy) can reduce weather‑associated headaches. The findings will be presented at the American Headache Society Annual Scientific Meeting in Orlando.
UC researcher secures $3.3M grant to study microplastics’ impact on heart
June 2, 2026
The National Institute of Environmental Health Sciences awarded a $3.3M grant to University of Cincinnati researcher Hong‑Sheng Wang, PhD, to study how microplastics and nanoplastics affect cardiovascular health.